121 203

Cited 0 times in

Current role of treatment in men with lower urinary tract symptoms combined with overactive bladder

DC FieldValueLanguage
dc.contributor.author이승환-
dc.date.accessioned2015-01-06T17:32:36Z-
dc.date.available2015-01-06T17:32:36Z-
dc.date.issued2014-
dc.identifier.issn2287-8882-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/100175-
dc.description.abstractLower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH) are highly prevalent in older men. The storage subcategory of LUTS is synonymous with overactive bladder (OAB) syndrome, which is an empirical diagnosis. Traditionally, alpha-blockers are widely prescribed to manage the LUTS of BPH, although storage symptoms may persist in many men despite treatment. Therefore, because therapies that target the prostate often fail to alleviate storage symptoms, they may not be the appropriate therapy for OAB. In past years, most physicians appeared to give more weight in elderly men to voiding symptoms than to storage symptoms and to be more concerned with initial treatment with anticholinergics for males with storage symptoms. Considering the recent increase in data on the efficacy and safety of combination treatment with alpha receptor antagonists and antimuscarinic agents, the standard pharmacologic treatment of patients with LUTS combined with OAB should be an alpha receptor antagonist and an antimuscarinic agent. Beta-3 adrenoreceptor agonists may also potentially be useful for the treatment of male LUTS combined with OAB.-
dc.description.statementOfResponsibilityopen-
dc.format.extent43~49-
dc.relation.isPartOfPROSTATE INTERNATIONAL-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.titleCurrent role of treatment in men with lower urinary tract symptoms combined with overactive bladder-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Urology (비뇨기과학)-
dc.contributor.googleauthorSeung Hwan Lee-
dc.contributor.googleauthorJi Youl Lee-
dc.identifier.doi10.12954/PI.14045-
dc.admin.authorfalse-
dc.admin.mappingfalse-
dc.contributor.localIdA02938-
dc.relation.journalcodeJ02559-
dc.identifier.eissn2287-903X-
dc.identifier.pmid25032191-
dc.subject.keywordOveractive urinary bladder-
dc.subject.keywordPharmacology-
dc.subject.keywordProstatic hyperplasia-
dc.contributor.alternativeNameLee, Seung Hwan-
dc.contributor.affiliatedAuthorLee, Seung Hwan-
dc.citation.volume2-
dc.citation.number2-
dc.citation.startPage43-
dc.citation.endPage49-
dc.identifier.bibliographicCitationPROSTATE INTERNATIONAL, Vol.2(2) : 43-49, 2014-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Urology (비뇨의학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.